Suspension of trading
Financial comparisons Exact Sciences Corporation
Stocks
EXAS
US30063P1057
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
23:00:00 20/03/2026 +03
|
5-day change | 1st Jan Change | ||
| 104.91 USD | +0.95% |
|
-.--% | +3.30% |
| 03-25 | Exact Sciences Corporation(NasdaqCM:EXAS) dropped from S&P Biotechnology Select Industry Index | CI |
| 03-25 | Exact Sciences Corporation(NasdaqCM:EXAS) dropped from S&P Global BMI Index | CI |
Main competitors
| Revenues (N-1) | Net Margin (N-1) | EBIT Margin (N-1) | ROE (N-1) | ROA (N-1) | Leverage (N-1) | ||
|---|---|---|---|---|---|---|---|
 | 3.25B | -6.4% | -2.5% | 0.54% | -3.55% | 3.4x | |
| 264M | -148.38% | -153.08% | -55.5% | - | 0.83x | |
| 277M | -21.48% | -20.62% | -27.84% | -11.31% | -8.26x | |
| 517M | 12.83% | 11.17% | 11.52% | - | -2.9x | |
| 380M | -5.62% | -8.1% | - | - | - | |
| 186M | -70.41% | -44.52% | -57.13% | -14.7% | -2.4x | |
| 329M | 10.18% | 7.29% | 4.81% | 3.94% | -2.66x | |
| 4.06M | -1,238.52% | -1,260.76% | - | - | - | |
| 27.83K | -46,364% | -47,282% | -30.03% | -25.14% | 3.43x | |
| 15.13M | -42.34% | -47% | -26.44% | -18.06% | - | |
| Average | 522M | -4,787.41% | -4,880.01% | -22.51% | -11.47% | -1.22x | |
| Weighted average by Cap. | 1.94B | -169.43% | -170.26% | -10.08% | -4.99% | 0.73x |
- Stock Market
- Stocks
- EXAS Stock
- Sector Exact Sciences Corporation
- Financial comparisons
Select your edition
All financial news and data tailored to specific country editions
